Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Comparative Research Needs New Approach To Answer Real-Life Questions

Executive Summary

To get the most out of the new funding for research on the comparative effectiveness of health care products and services, research needs to go in new directions so that it can answer real-world questions, two former CMS officials said at a recent forum at the American Enterprise Institute

You may also be interested in...



Three Amendments On Comparative Effectiveness Research Fail During Finance Committee Markup

Chairman Baucus' attempt to find middle ground on one amendment is met with a hardline stance from Sen. Kyl, leading to the amendment's ultimate demise.

CER Draft Definition Raises No Red Flags, But More Clarity Sought

The draft definition of comparative effectiveness research released by the Federal Coordinating Council for Comparative Effectiveness Research indicates a lot of flexibility in terms of what kinds of research may be conducted

CER Draft Definition Raises No Red Flags, But More Clarity Sought

The draft definition of comparative effectiveness research released by the Federal Coordinating Council for Comparative Effectiveness Research indicates a lot of flexibility in terms of what kinds of research may be conducted

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel